Cargando…

A LUHMES 3D dopaminergic neuronal model for neurotoxicity testing allowing long-term exposure and cellular resilience analysis

Several shortcomings of current Parkinson’s disease (PD) models limit progress in identification of environmental contributions to disease pathogenesis. The conditionally immortalized cell line LUHMES promises to make human dopaminergic neuronal cultures more easily available, but these cells are di...

Descripción completa

Detalles Bibliográficos
Autores principales: Smirnova, L., Harris, G., Delp, J., Valadares, M., Pamies, D., Hogberg, H. T., Waldmann, T., Leist, M., Hartung, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065586/
https://www.ncbi.nlm.nih.gov/pubmed/26647301
http://dx.doi.org/10.1007/s00204-015-1637-z
_version_ 1782460338761891840
author Smirnova, L.
Harris, G.
Delp, J.
Valadares, M.
Pamies, D.
Hogberg, H. T.
Waldmann, T.
Leist, M.
Hartung, T.
author_facet Smirnova, L.
Harris, G.
Delp, J.
Valadares, M.
Pamies, D.
Hogberg, H. T.
Waldmann, T.
Leist, M.
Hartung, T.
author_sort Smirnova, L.
collection PubMed
description Several shortcomings of current Parkinson’s disease (PD) models limit progress in identification of environmental contributions to disease pathogenesis. The conditionally immortalized cell line LUHMES promises to make human dopaminergic neuronal cultures more easily available, but these cells are difficult to culture for extended periods of time. We overcame this problem by culturing them in 3D with minor medium modifications. The 3D neuronal aggregates allowed penetration by small molecules and sufficient oxygen and nutrient supply for survival of the innermost cells. Using confocal microscopy, gene expression, and flow cytometry, we characterized the 3D model and observed a highly reproducible differentiation process. Visualization and quantification of neurites in aggregates was achieved by adding 2 % red fluorescent protein-transfected LUHMES cells. The mitochondrial toxicants and established experimental PD agents, rotenone and MPP(+), perturbed genes involved in one-carbon metabolism and transsulfuration pathways (ASS1, CTH, and SHTM2) as in 2D cultures. We showed, for the first time in LUHMES, down-regulation of mir-7, a miRNA known to target alpha-synuclein and to be involved in PD. This was observed as early as 12 h after rotenone exposure, when pro-apoptotic mir-16 and rotenone-sensitive mir-210 were not yet significantly perturbed. Finally, washout experiments demonstrated that withdrawal of rotenone led to counter-regulation of mir-7 and ASS1, CTH, and SHTM2 genes. This suggests a possible role of these genes in direct cellular response to the toxicant, and the model appears to be suitable to address the processes of resilience and recovery in neurotoxicology and Parkinson’s disease in future studies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00204-015-1637-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5065586
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-50655862016-10-28 A LUHMES 3D dopaminergic neuronal model for neurotoxicity testing allowing long-term exposure and cellular resilience analysis Smirnova, L. Harris, G. Delp, J. Valadares, M. Pamies, D. Hogberg, H. T. Waldmann, T. Leist, M. Hartung, T. Arch Toxicol In Vitro Systems Several shortcomings of current Parkinson’s disease (PD) models limit progress in identification of environmental contributions to disease pathogenesis. The conditionally immortalized cell line LUHMES promises to make human dopaminergic neuronal cultures more easily available, but these cells are difficult to culture for extended periods of time. We overcame this problem by culturing them in 3D with minor medium modifications. The 3D neuronal aggregates allowed penetration by small molecules and sufficient oxygen and nutrient supply for survival of the innermost cells. Using confocal microscopy, gene expression, and flow cytometry, we characterized the 3D model and observed a highly reproducible differentiation process. Visualization and quantification of neurites in aggregates was achieved by adding 2 % red fluorescent protein-transfected LUHMES cells. The mitochondrial toxicants and established experimental PD agents, rotenone and MPP(+), perturbed genes involved in one-carbon metabolism and transsulfuration pathways (ASS1, CTH, and SHTM2) as in 2D cultures. We showed, for the first time in LUHMES, down-regulation of mir-7, a miRNA known to target alpha-synuclein and to be involved in PD. This was observed as early as 12 h after rotenone exposure, when pro-apoptotic mir-16 and rotenone-sensitive mir-210 were not yet significantly perturbed. Finally, washout experiments demonstrated that withdrawal of rotenone led to counter-regulation of mir-7 and ASS1, CTH, and SHTM2 genes. This suggests a possible role of these genes in direct cellular response to the toxicant, and the model appears to be suitable to address the processes of resilience and recovery in neurotoxicology and Parkinson’s disease in future studies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00204-015-1637-z) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2015-12-08 2016 /pmc/articles/PMC5065586/ /pubmed/26647301 http://dx.doi.org/10.1007/s00204-015-1637-z Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle In Vitro Systems
Smirnova, L.
Harris, G.
Delp, J.
Valadares, M.
Pamies, D.
Hogberg, H. T.
Waldmann, T.
Leist, M.
Hartung, T.
A LUHMES 3D dopaminergic neuronal model for neurotoxicity testing allowing long-term exposure and cellular resilience analysis
title A LUHMES 3D dopaminergic neuronal model for neurotoxicity testing allowing long-term exposure and cellular resilience analysis
title_full A LUHMES 3D dopaminergic neuronal model for neurotoxicity testing allowing long-term exposure and cellular resilience analysis
title_fullStr A LUHMES 3D dopaminergic neuronal model for neurotoxicity testing allowing long-term exposure and cellular resilience analysis
title_full_unstemmed A LUHMES 3D dopaminergic neuronal model for neurotoxicity testing allowing long-term exposure and cellular resilience analysis
title_short A LUHMES 3D dopaminergic neuronal model for neurotoxicity testing allowing long-term exposure and cellular resilience analysis
title_sort luhmes 3d dopaminergic neuronal model for neurotoxicity testing allowing long-term exposure and cellular resilience analysis
topic In Vitro Systems
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065586/
https://www.ncbi.nlm.nih.gov/pubmed/26647301
http://dx.doi.org/10.1007/s00204-015-1637-z
work_keys_str_mv AT smirnoval aluhmes3ddopaminergicneuronalmodelforneurotoxicitytestingallowinglongtermexposureandcellularresilienceanalysis
AT harrisg aluhmes3ddopaminergicneuronalmodelforneurotoxicitytestingallowinglongtermexposureandcellularresilienceanalysis
AT delpj aluhmes3ddopaminergicneuronalmodelforneurotoxicitytestingallowinglongtermexposureandcellularresilienceanalysis
AT valadaresm aluhmes3ddopaminergicneuronalmodelforneurotoxicitytestingallowinglongtermexposureandcellularresilienceanalysis
AT pamiesd aluhmes3ddopaminergicneuronalmodelforneurotoxicitytestingallowinglongtermexposureandcellularresilienceanalysis
AT hogberght aluhmes3ddopaminergicneuronalmodelforneurotoxicitytestingallowinglongtermexposureandcellularresilienceanalysis
AT waldmannt aluhmes3ddopaminergicneuronalmodelforneurotoxicitytestingallowinglongtermexposureandcellularresilienceanalysis
AT leistm aluhmes3ddopaminergicneuronalmodelforneurotoxicitytestingallowinglongtermexposureandcellularresilienceanalysis
AT hartungt aluhmes3ddopaminergicneuronalmodelforneurotoxicitytestingallowinglongtermexposureandcellularresilienceanalysis
AT smirnoval luhmes3ddopaminergicneuronalmodelforneurotoxicitytestingallowinglongtermexposureandcellularresilienceanalysis
AT harrisg luhmes3ddopaminergicneuronalmodelforneurotoxicitytestingallowinglongtermexposureandcellularresilienceanalysis
AT delpj luhmes3ddopaminergicneuronalmodelforneurotoxicitytestingallowinglongtermexposureandcellularresilienceanalysis
AT valadaresm luhmes3ddopaminergicneuronalmodelforneurotoxicitytestingallowinglongtermexposureandcellularresilienceanalysis
AT pamiesd luhmes3ddopaminergicneuronalmodelforneurotoxicitytestingallowinglongtermexposureandcellularresilienceanalysis
AT hogberght luhmes3ddopaminergicneuronalmodelforneurotoxicitytestingallowinglongtermexposureandcellularresilienceanalysis
AT waldmannt luhmes3ddopaminergicneuronalmodelforneurotoxicitytestingallowinglongtermexposureandcellularresilienceanalysis
AT leistm luhmes3ddopaminergicneuronalmodelforneurotoxicitytestingallowinglongtermexposureandcellularresilienceanalysis
AT hartungt luhmes3ddopaminergicneuronalmodelforneurotoxicitytestingallowinglongtermexposureandcellularresilienceanalysis